HLN

Haleon plc

OTC · Perfumes, Cosmetics & Other Toilet Preparations · Inc. X0 · CIK 0001900304
$9.12 +1.79% $40.6B
Vol
Market Cap$40.6B
Cap SizeLarge Cap
Inst. Holders8 funds
Inst. Value$3.1B
Inst. Activity2 buys / 1 sells
Exchange OTC·Sector Perfumes, Cosmetics & Other Toilet Preparations·Inc. X0·CIK 0001900304·Prev Close $8.96

Recent Activity

Inst.
NORGES BANK — NEW
16,175,000 shares ($163.5M)
Inst.
CHARLES SCHWAB INVESTMENT MANAGEMENT — ADD
567,581 shares ($5.7M)
May 21, 2026 other
‘For The Assist’: Haleon Canada launches national campaign with Canada Soccer to celebrate the small health supports behind Canadian wellbeing
New Haleon Canada creative featuring Richie Laryea anchors integrated campaign spanning media, retai
Mar 27, 2026 Event
ALLI
Supplemental Approval — Labeling — ORLISTAT — CAPSULE — ORAL

Price Targets

Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$11.74 (Jan 2026)
Current $9.12 Low $10.00 Median $11.85 High $13.85 5 analysts
$10.00 $13.85

Analyst Ratings

Historical distribution77% buy · 26 analysts · last covering-analyst action Jan 2026
7Strong Buy
13Buy
4Hold
2Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Jan 23, 2026 Barclays UPGRADE Equal-Weight → Overweight
Sep 16, 2025 Barclays DOWNGRADE Overweight → Equal-Weight
Sep 20, 2024 Morgan Stanley MAINTAIN Overweight → Overweight
Mar 26, 2024 Argus Research MAINTAIN Buy → Buy
Nov 1, 2023 Morgan Stanley INITIATE Overweight

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Next FY $0.61 $0.60 — $0.62 9% YoY 3
Current FY $0.56 ▲ +0.7% $0.55 — $0.56 10% YoY 3

Top Institutional Holders

FundValueMove
DODGE & COX$1.5B
FMR LLC$1.1B
MORGAN STANLEY$217.3MADD
NORGES BANK$163.5MNEW
BANK OF AMERICA CORP$94.5MDOUBLED
8 institutional holders with $3.1B total value (311,086,603 shares) as of 2025-Q4. Top holders: DODGE, FMR, MORGAN. Net buying activity: 2 institutions added/increased vs 1 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1DODGE & COX151,755,452$1.5B48.8%
2FMR LLC107,941,807$1.1B34.7%
3MORGAN STANLEY21,495,383$217.3M6.9%ADD +72.5%
4NORGES BANK16,175,000$163.5M5.2%NEW
5BANK OF AMERICA CORP /DE/9,347,998$94.5M3.0%DOUBLED +116.7%
6WELLS FARGO & COMPANY/MN3,726,852$37.7M1.2%
7CHARLES SCHWAB INVESTMENT MANAGEMENT INC567,581$5.7M0.2%ADD +26.0%
8Tweedy, Browne Co LLC76,530$773.7K0.0%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
NORGES BANKNEW16,175,000$163.5M2025-Q4
CHARLES SCHWAB INVESTMENT MANAGEMENT INCADD450,410567,581+26.0%$5.7M2025-Q4
RENAISSANCE TECHNOLOGIES LLCEXIT1,434,3990-100.0%$0.002025-Q4
RENAISSANCE TECHNOLOGIES LLCNEAR_EXIT7,786,6991,434,399-81.6%$12.9M2025-Q3
UBS Group AGNEAR_EXIT6,118,861480,317-92.2%$4.3M2025-Q3
TWO SIGMA INVESTMENTS, LPEXIT35,8370-100.0%$0.002025-Q3
NORGES BANKEXIT275,0000-100.0%$0.002025-Q3
MORGAN STANLEYADD10,279,45617,734,937+72.5%$183.9M2025-Q2
BANK OF AMERICA CORP /DE/DOUBLED5,714,21212,384,135+116.7%$128.4M2025-Q2
RENAISSANCE TECHNOLOGIES LLCDOUBLED1,239,6997,786,699+528.1%$80.7M2025-Q2
UBS Group AGTRIM14,360,8996,118,861-57.4%$63.5M2025-Q2
CHARLES SCHWAB INVESTMENT MANAGEMENT INCADD342,213460,850+34.7%$4.8M2025-Q2
NORGES BANKNEW275,000$2.9M2025-Q2
TWO SIGMA INVESTMENTS, LPTRIM115,63735,837-69.0%$371.6K2025-Q2
UBS Group AGDOUBLED6,728,88614,360,899+113.4%$147.8M2025-Q1
RENAISSANCE TECHNOLOGIES LLCDOUBLED613,0991,239,699+102.2%$12.8M2025-Q1
CHARLES SCHWAB INVESTMENT MANAGEMENT INCADD265,744342,213+28.8%$3.5M2025-Q1
TWO SIGMA INVESTMENTS, LPTRIM202,492115,637-42.9%$1.2M2025-Q1
UBS Group AGDOUBLED1,352,6106,728,886+397.5%$64.2M2024-Q4
CITADEL ADVISORS LLCDOUBLED1,224,8766,217,493+407.6%$59.3M2024-Q4
RENAISSANCE TECHNOLOGIES LLCTRIM1,061,399613,099-42.2%$5.8M2024-Q4
CHARLES SCHWAB INVESTMENT MANAGEMENT INCADD203,583265,744+30.5%$2.5M2024-Q4
CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW203,583$2.2M2024-Q3

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Jan 2026): 77% buy across 26 analysts — 7 strong buy, 13 buy, 4 hold, 2 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$11.74 mean target (Jan 2026)
$10.00 Low $13.85 High
MetricValue
Current Price$9.12
Target Low$10.00
Target Mean$11.74
Target Median$11.85
Target High$13.85
# Analysts5
Recommendation— (no recent coverage)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Next FY
2027-12-31
$0.61 $0.60 $0.62 9.4% -0.0% 1↑ 1↓ $11.9B 4.3% 3
Current Q
2026-03-31
$0.00 $0.00 $0.00 $2.9B 0.6%
Current FY
2026-12-31
$0.56 $0.55 $0.56 9.6% +0.7% 1↑ 1↓ $11.4B 3.2% 3
Next Q
2026-06-30
$0.00 $0.00 $0.00 $2.7B 4.0%
4 analyst firms have rated this stock: 2 upgrades, 1 downgrades, 3 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Jan 23, 2026 Barclays UPGRADE Equal-Weight Overweight
Sep 16, 2025 Barclays DOWNGRADE Overweight Equal-Weight
Sep 20, 2024 Morgan Stanley MAINTAIN Overweight Overweight
Mar 26, 2024 Argus Research MAINTAIN Buy Buy
Nov 1, 2023 Morgan Stanley INITIATE Overweight
Apr 6, 2023 Argus Research UPGRADE Hold Buy
Sep 28, 2022 Argus Research INITIATE Hold
Jul 29, 2022 Deutsche Bank INITIATE Hold

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 202671342077%
May 1, 202671342077%
Apr 1, 202671332080%
Mar 1, 202671332080%
Feb 1, 202671332080%
Jan 1, 202671061071%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 21, 2026
other
‘For The Assist’: Haleon Canada launches national campaign with Canada Soccer to celebrate the small health supports behind Canadian wellbeing
New Haleon Canada creative featuring Richie Laryea anchors integrated campaign spanning media, retail, and cross-country experiential <pre>New Haleon
May 21, 2026
short_volume
Short Volume: HLN — 62.7% short (1.7M / 2.7M)
Short: 1,688,435 | Exempt: 2,097 | TRF Vol: 2,691,942 | Short Ratio: 62.7% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: HLN — 66.2% short (1.8M / 2.7M)
Short: 1,756,661 | Exempt: 1,315 | TRF Vol: 2,655,019 | Short Ratio: 66.2% | Off-exchange volume (dark pool + OTC)
May 12, 2026
short_interest
FTD: HLN — 1,301,224 shares ($11.7M) failed to deliver
Settlement: 20260512, Price: $8.98, FTD Value: $11,684,991.52, HALEON PLC ADR (GBR)
May 11, 2026
short_interest
FTD: HLN — 396,113 shares ($3.6M) failed to deliver
Settlement: 20260511, Price: $9.11, FTD Value: $3,608,589.43, HALEON PLC ADR (GBR)
May 8, 2026
short_volume
Short Volume: HLN — 68.0% short (5.0M / 7.3M)
Short: 4,985,703 | Exempt: 7,908 | TRF Vol: 7,330,076 | Short Ratio: 68.0% | Off-exchange volume (dark pool + OTC)
May 8, 2026
short_interest
FTD: HLN — 201,161 shares ($1.9M) failed to deliver
Settlement: 20260508, Price: $9.30, FTD Value: $1,870,797.3, HALEON PLC ADR (GBR)
May 4, 2026
other
Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits
New science-backed daily multivitamin specially formulated with essential vitamins and minerals to meet nutritional and health needs of older adults <
Apr 30, 2026
short_interest
FTD: HLN — 101,242 shares ($0.9M) failed to deliver
Settlement: 20260430, Price: $9.30, FTD Value: $941,550.6, HALEON PLC ADR (GBR)
Apr 21, 2026
short_volume
Short Volume: HLN — 66.0% short (2.4M / 3.6M)
Short: 2,380,433 | Exempt: 2,395 | TRF Vol: 3,608,903 | Short Ratio: 66.0% | Off-exchange volume (dark pool + OTC)
Apr 15, 2026
short_volume
Short Volume: HLN — 63.1% short (7.0M / 11.0M)
Short: 6,955,765 | Exempt: 1,393 | TRF Vol: 11,026,662 | Short Ratio: 63.1% | Off-exchange volume (dark pool + OTC)
Apr 2, 2026
short_interest
FTD: HLN — 72,980 shares ($0.7M) failed to deliver
Settlement: 20260402, Price: $9.97, FTD Value: $727,610.6, HALEON PLC ADR (GBR)
Mar 30, 2026
short_interest
FTD: HLN — 61,357 shares ($0.6M) failed to deliver
Settlement: 20260330, Price: $9.80, FTD Value: $601,298.6, HALEON PLC ADR (GBR)
Mar 27, 2026
FDA
ALLI
Supplemental Approval — Labeling — ORLISTAT — CAPSULE — ORAL
Mar 26, 2026
short_volume
Short Volume: HLN — 61.5% short (2.0M / 3.3M)
Short: 2,025,041 | Exempt: 604 | TRF Vol: 3,291,820 | Short Ratio: 61.5% | Off-exchange volume (dark pool + OTC)
Mar 24, 2026
short_volume
Short Volume: HLN — 66.4% short (3.3M / 5.0M)
Short: 3,291,383 | Exempt: 15,762 | TRF Vol: 4,959,095 | Short Ratio: 66.4% | Off-exchange volume (dark pool + OTC)